Increased Akt Signaling Resulting from the Loss of Androgen Responsiveness in Prostate Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|20|1|144-157

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.20, Iss.1, 2013-01, pp. : 144-157

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ADDENDUM: Increased Akt Signaling Resulting from the Loss of Androgen Responsiveness in Prostate Cancer. Dulinska-Litewka J, McCubrey JA, Laidler P. Curr. Med. Chem., 2013, 20(1), 144-157.

By  

Current Medicinal Chemistry, Vol. 21, Iss. 32, 2014-10 ,pp. : 3717-3717

Bentham Science Publishers

Access to resources Recommend Favorite

Akt in Prostate Cancer: Possible Role in Androgen-Independence

By  

Current Drug Metabolism, Vol. 4, Iss. 6, 2003-12 ,pp. : 487-496

Bentham Science Publishers

Access to resources Recommend Favorite

Cross-Talk Between the Androgen Receptor and the Phosphatidylinositol 3-Kinase/Akt Pathway in Prostate Cancer

By  

Current Cancer Drug Targets, Vol. 7, Iss. 6, 2007-09 ,pp. : 591-604

Bentham Science Publishers

Access to resources Recommend Favorite

Genome-Wide Integrated Analyses of Androgen Receptor Signaling in Prostate Cancer Based on High-Throughput Technology

By  

Current Drug Targets, Vol. 14, Iss. 4, 2013-04 ,pp. : 472-480

Bentham Science Publishers

Access to resources Recommend Favorite

Androgen deprivation therapy for prostate cancer

By Singer Eric A   Golijanin Dragan J   Miyamoto Hiroshi   Messing Edward M  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 2, 2008-02 ,pp. : 211-228

Informa Healthcare

Access to resources Recommend Favorite